TNF Inhibitor denied for missing prior authorization by Humana?

Humana's specific coverage criteria for tnf inhibitor are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for TNF Inhibitors — and Why You Can Appeal a Denial

All TNF inhibitors are specialty biologics that Humana requires prior authorization (PA) before dispensing. A prior-auth-required denial can mean one of two things: (1) no PA was submitted before the prescription was filled, resulting in a retroactive denial, or (2) a PA was submitted but Humana denied it — typically citing insufficient documentation of medical necessity, incomplete step-therapy history, or a formulary issue. Understanding which scenario you face determines the right appeal strategy.

## Why This Is Appealable

If the PA was denied on clinical grounds, you have the full right to appeal that determination. Under ACA §2719 and ERISA §503, you are entitled to a full-and-fair internal appeal reviewed by a clinical peer, followed — if needed — by an independent external review by a certified independent review organization (IRO). The external review window is generally within approximately four months of the denial. Expedited review, often resolved within 72 hours, is available when your health would be seriously jeopardized by the standard timeline. If the denial was purely administrative (no PA submitted), your prescriber may be able to submit a retroactive PA with supporting documentation in certain circumstances — ask Humana's provider services line.

## The Appeal Process and Timeline

1. Confirm the specific denial reason: request the full denial letter and the PA criteria Humana applied. 2. Peer-to-peer review: your prescriber can request a direct phone review with Humana's medical director — this is often the fastest path to reversal for TNF inhibitor PAs. 3. File the internal appeal: submit within the deadline in your denial letter (often 60–180 days). Include all clinical documentation. 4. Escalate to external review if the internal appeal is upheld. 5. Expedited track: request if standard timing poses clinical risk.

## Documentation to Gather

• Humana's prior authorization criteria: request the specific PA requirements for the TNF inhibitor prescribed — each criterion must be answered in your appeal.
• Diagnosis confirmation: specialist notes, diagnostic records, and test results confirming the covered indication.
• Disease severity documentation: objective chart findings demonstrating clinical need, using your prescriber's own language and measurements.
• Prior treatment history: a chronological record of all prior therapies attempted — especially any step-therapy requirements — with dates, durations, and documented outcomes (inadequate response, adverse effects, or contraindication).
• Prescriber's medical-necessity letter: a point-by-point letter addressing each PA criterion, tied to specific chart findings.
• FDA-approved prescribing label: confirms the indication and patient population for the requested drug.

## Criteria-Mapping Structure

Build your appeal around Humana's PA criteria document:

| PA Requirement | Supporting Evidence | |---|---| | Covered diagnosis | [Specialist note; diagnostic record] | | Step-therapy completion or exception | [Prior medication list with dates and outcomes] | | Disease severity | [Chart objective findings; prescriber letter] | | Prescriber specialty or qualifications (if required) | [Prescriber credentials; referral if needed] |

A peer-to-peer review combined with a criterion-mapped appeal letter is the most effective approach for TNF inhibitor prior-auth denials.